Insider · CIK 0001815485
Xiang Liu
other
Files at BME (BlackRock Health Sciences Trust), BMEZ (BlackRock Health Sciences Term Trust). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | BMEZ BlackRock Health Sciences Term Trust | MOption exercise Common Stock | +225 | - | - | 225 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | MOption exercise Common Stock | +281 | - | - | 281 | Feb 4, 2025 |
| Jan 31, 2025 | BMEZ BlackRock Health Sciences Term Trust | DDisposition to issuer Common Stock | -225 | $16.49 | $3,712 | 0 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | DDisposition to issuer Common Stock | -281 | $40.92 | $11k | 0 | Feb 4, 2025 |
| Jan 31, 2025 | BMEZ BlackRock Health Sciences Term Trust | AGrant or award Phantom Sharesderivative | +1,388 | $16.49 | $23k | 1,388 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | AGrant or award Phantom Sharesderivative | +559 | $40.92 | $23k | 559 | Feb 4, 2025 |
| Jan 31, 2025 | BMEZ BlackRock Health Sciences Term Trust | MOption exercise Phantom Sharesderivative | -225 | - | - | 450 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | MOption exercise Phantom Sharesderivative | -80 | - | - | 159 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | MOption exercise Phantom Sharesderivative | -92 | - | - | 92 | Feb 4, 2025 |
| Jan 31, 2025 | BME BlackRock Health Sciences Trust | MOption exercise Phantom Sharesderivative | -109 | - | - | 0 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.